These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37990638)

  • 1. 5α-Tetrahydrocorticosterone: A topical anti-inflammatory glucocorticoid with an improved therapeutic index in a murine model of dermatitis.
    Livingstone DEW; Sooy K; Sykes C; Webster SP; Walker BR; Andrew R
    Br J Pharmacol; 2024 Apr; 181(8):1256-1267. PubMed ID: 37990638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safer topical treatment for inflammation using 5α-tetrahydrocorticosterone in mouse models.
    Gastaldello A; Livingstone DE; Abernethie AJ; Tsang N; Walker BR; Hadoke PW; Andrew R
    Biochem Pharmacol; 2017 Apr; 129():73-84. PubMed ID: 28131845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mechanisms of angiostasis caused by the anti-inflammatory steroid 5α-tetrahydrocorticosterone versus conventional glucocorticoids.
    Abernethie AJ; Gastaldello A; Maltese G; Morgan RA; McInnes KJ; Small GR; Walker BR; Livingstone DE; Hadoke PW; Andrew R
    Eur J Pharmacol; 2022 Aug; 929():175111. PubMed ID: 35738450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5α-reduced glucocorticoids exhibit dissociated anti-inflammatory and metabolic effects.
    Yang C; Nixon M; Kenyon CJ; Livingstone DE; Duffin R; Rossi AG; Walker BR; Andrew R
    Br J Pharmacol; 2011 Nov; 164(6):1661-71. PubMed ID: 21542833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cariniana domestica fruit peels present topical anti-inflammatory efficacy in a mouse model of skin inflammation.
    Milani GB; Camponogara C; Piana M; Silva CR; Oliveira SM
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):513-528. PubMed ID: 30617548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor.
    McInnes KJ; Kenyon CJ; Chapman KE; Livingstone DE; Macdonald LJ; Walker BR; Andrew R
    J Biol Chem; 2004 May; 279(22):22908-12. PubMed ID: 15044432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oleic acid exhibits an expressive anti-inflammatory effect in croton oil-induced irritant contact dermatitis without the occurrence of toxicological effects in mice.
    Pegoraro NS; Camponogara C; Cruz L; Oliveira SM
    J Ethnopharmacol; 2021 Mar; 267():113486. PubMed ID: 33091495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasturtium officinale R. Br. effectively reduces the skin inflammation induced by croton oil via glucocorticoid receptor-dependent and NF-κB pathways without causing toxicological effects in mice.
    Camponogara C; Silva CR; Brusco I; Piana M; Faccin H; de Carvalho LM; Schuch A; Trevisan G; Oliveira SM
    J Ethnopharmacol; 2019 Jan; 229():190-204. PubMed ID: 30339978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical glucocorticoids and suppression of contact sensitivity. A mouse bioassay of anti-inflammatory effects.
    Bäck O; Egelrud T
    Br J Dermatol; 1985 May; 112(5):539-45. PubMed ID: 4005154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated topical application of glucocorticoids augments irritant chemical-triggered scratching in mice.
    Fujii Y; Sengoku T; Takakura S
    Arch Dermatol Res; 2010 Nov; 302(9):645-52. PubMed ID: 20549223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Applications of a Novel Emollient Inhibit Inflammation in Murine Models of Acute Contact Dermatitis.
    Wen S; Sun M; Ye L; Yang B; Hu L; Man MQ
    Biomed Res Int; 2021; 2021():5594646. PubMed ID: 33954180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tabernaemontana catharinensis leaves effectively reduce the irritant contact dermatitis by glucocorticoid receptor-dependent pathway in mice.
    Camponogara C; Casoti R; Brusco I; Piana M; Boligon AA; Cabrini DA; Trevisan G; Ferreira J; Silva CR; Oliveira SM
    Biomed Pharmacother; 2019 Jan; 109():646-657. PubMed ID: 30404072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.
    Schäcke H; Zollner TM; Döcke WD; Rehwinkel H; Jaroch S; Skuballa W; Neuhaus R; May E; Zügel U; Asadullah K
    Br J Pharmacol; 2009 Oct; 158(4):1088-103. PubMed ID: 19422381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
    Prakash A; Benfield P
    Drugs; 1998 Jan; 55(1):145-63. PubMed ID: 9463794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin.
    Klopot A; Baida G; Bhalla P; Haegeman G; Budunova I
    J Cancer Prev; 2015 Dec; 20(4):250-9. PubMed ID: 26734587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical glucocorticoid augments IgE-mediated passive cutaneous anaphylaxis in Balb/C mice and mast cell deficient WBB6F1 v/v mice.
    Katayama I; Igawa K; Minatohara K; Nishioka K
    Clin Exp Allergy; 1997 Dec; 27(12):1477-83. PubMed ID: 9433944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin ointment, a new treatment for skin inflammatory conditions.
    Adami M; Prudente Ada S; Mendes DA; Horinouchi CD; Cabrini DA; Otuki MF
    J Dermatol Sci; 2012 May; 66(2):127-35. PubMed ID: 22455735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudoceramide stimulates peroxisome proliferator-activated receptor-α expression in a murine model of atopic dermatitis: molecular basis underlying the anti-inflammatory effect and the preventive effect against steroid-induced barrier impairment.
    Lee SE; Jung MK; Oh SJ; Jeong SK; Lee SH
    Arch Dermatol Res; 2015 Nov; 307(9):781-92. PubMed ID: 26121942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hairless mouse as a model for study of local and systemic atrophogenic effects following topical application of corticosteroids.
    van den Hoven WE; van den Berg TP; Korstanje C
    Acta Derm Venereol; 1991; 71(1):29-31. PubMed ID: 1676210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical valrubicin application reduces skin inflammation in murine models.
    Hauge E; Christiansen H; Rosada C; de Darkó E; Dam TN; Stenderup K
    Br J Dermatol; 2012 Aug; 167(2):288-95. PubMed ID: 22458650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.